Ativan and Liothyronine sodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ativan (lorazepam) and Liothyronine sodium (liothyronine sodium). Common drug interactions include globulins increased among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Ativan and Liothyronine sodium. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Ativan?

Ativan has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 78,506 Ativan users. Check the latest studies of Ativan.

What is Liothyronine sodium?

Liothyronine sodium has active ingredients of liothyronine sodium. It is often used in hypothyroidism. eHealthMe is studying from 4,275 Liothyronine sodium users. Check the latest studies of Liothyronine sodium.



On Jul, 18, 2026

32 people who take Ativan and Liothyronine sodium together, and have interactions are studied.

Ativan and Liothyronine sodium drug interactions.

What are the common drug interactions of Ativan and Liothyronine Sodium, by gender? *:

female:

  1. Globulins increased
  2. Hypnagogic hallucination
  3. Intervertebral disc compression (spinal disc compression)
  4. Irritability
  5. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  6. Poor quality sleep
  7. Renal disorder (kidney disease)
  8. Snoring
  9. Somnambulism (sleep walking)
  10. Somnolence (a state of near-sleep, a strong desire for sleep)

male:

  1. Fatigue (feeling of tiredness)
  2. Abdominal pain lower
  3. Weight decreased
  4. Asthenia (weakness)
  5. Back disorder
  6. Blindness
  7. Cluster headache (one-sided head pain with tearing)
  8. Cough
  9. Drug intolerance (drug sensitivity)
  10. Dyspepsia (indigestion)

What are the common drug interactions of Ativan and Liothyronine Sodium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Decreased appetite
  2. Irritability
  3. Nausea (feeling of having an urge to vomit)
  4. Vomiting
  5. Weight decreased

30-39:

  1. Suicidal ideation
  2. Vomiting
  3. Bladder disorder
  4. Blindness
  5. Drug withdrawal convulsions
  6. Renal disorder (kidney disease)
  7. Tremor (trembling or shaking movements in one or more parts of your body)
  8. Fatigue (feeling of tiredness)
  9. Hypoaesthesia (reduced sense of touch or sensation)
  10. Myalgia (muscle pain)

40-49:

  1. Back injury
  2. Nerve degeneration (weakness in functioning of nerve due to degeneration)
  3. Spinal disorder (disease of spine a back bone)
  4. Adjustment disorder with depressed mood
  5. Aphonia (inability to produce voice)
  6. Contusion (a type of hematoma of tissue in which capillaries)
  7. Crying
  8. Ear infection
  9. Haemorrhage (bleeding)
  10. Hypnagogic hallucination

50-59:

n/a

60+:

  1. Abdominal pain lower
  2. Decreased appetite
  3. Cough
  4. Headache (pain in head)
  5. Hyperhidrosis (abnormally increased sweating)
  6. Muscle rigidity (muscle stiffness)
  7. Tachyphrenia (abnormally rapid mental activity)
  8. Depression
  9. Diarrhoea
  10. Fatigue (feeling of tiredness)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 11 people, 34.38%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 10 people, 31.25%
  3. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 5 people, 15.62%
  4. Type 1 Diabetes: 2 people, 6.25%
  5. Renal Cell Carcinoma (a kidney cancer): 2 people, 6.25%
  6. Middle Insomnia (difficulty returning to sleep after awakening either in the middle of the night): 2 people, 6.25%
  7. Insomnia (sleeplessness): 2 people, 6.25%
  8. Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 2 people, 6.25%
  9. Growth Hormone Deficiency: 2 people, 6.25%
  10. Depression: 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Ativan and Liothyronine sodium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ativan and Liothyronine sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ativan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Liothyronine sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ativan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Liothyronine sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lorazepam and liothyronine sodium (the active ingredients of Ativan and Liothyronine sodium, respectively), and Ativan and Liothyronine sodium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: